Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

NCT01277302 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01277302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01277302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Lead sponsor
Genentech, Inc.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2011
Completion date
October 31, 2012
Enrollment
202 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema